Androgen synthesis inhibitors are second-generation androgen receptor medicines that inhibit the production of androgens, which aids in the treatment of prostate cancer. Androgen synthesis inhibitors suppress the CYP17 enzyme, which is required for the body to create testosterone. This enzyme is found in the testicles, adrenal glands, and prostate tumour tissues. It is more effective in decreasing testosterone levels.